Assignee

FORMA THERAPEUTICS INC

US123 patents

Top patents by PatentIndex Score

US10112915B2Oct 30, 2018

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC17 citations94

US10532047B2Jan 14, 2020

Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile

FORMA THERAPEUTICS INC12 citations94

US10414752B2Sep 17, 2019

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC19 citations94

US10407418B2Sep 10, 2019

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC16 citations94

US10377773B2Aug 13, 2019

Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC18 citations94

US10377767B2Aug 13, 2019

Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC16 citations94

US10351571B2Jul 16, 2019

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC15 citations94

US10183934B2Jan 22, 2019

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC27 citations94

US10005734B2Jun 26, 2018

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC25 citations94

US10000495B2Jun 19, 2018

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC21 citations94

US9938300B2Apr 10, 2018

Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC23 citations94

US9840491B2Dec 12, 2017

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC22 citations94

US9834539B2Dec 5, 2017

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC28 citations94

US9815817B2Nov 14, 2017

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC24 citations94

US9771349B2Sep 26, 2017

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC27 citations94

US9624216B2Apr 18, 2017

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC26 citations94

US9624175B2Apr 18, 2017

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC25 citations94

US10513501B2Dec 24, 2019

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC11 citations93

US10494351B2Dec 3, 2019

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC12 citations93

US10494352B2Dec 3, 2019

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC12 citations93

US10479772B2Nov 19, 2019

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC6 citations93

US10464910B2Nov 5, 2019

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC12 citations93

US10464909B2Nov 5, 2019

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC12 citations93

US10457652B2Oct 29, 2019

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

FORMA THERAPEUTICS INC12 citations93

US10377760B2Aug 13, 2019

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC17 citations93

US10336722B2Jul 2, 2019

Tetrahydroquinoline compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC22 citations93

US9902728B2Feb 27, 2018

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC24 citations93

US9422281B2Aug 23, 2016

Benzopiperazine compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC25 citations93

US9388161B2Jul 12, 2016

Tetrahydroquinoline compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC34 citations93

US10513507B2Dec 24, 2019

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC9 citations92

US10472371B2Nov 12, 2019

Compositions for activating pyruvate kinase

FORMA THERAPEUTICS INC13 citations92

Showing the top 50 of 123 patents by PatentIndex Score.

FORMA THERAPEUTICS INC

Top patents by PatentIndex Score

3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors

3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors

Compositions for activating pyruvate kinase

Activating pyruvate kinase R

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Tetrahydroquinoline compositions as BET bromodomain inhibitors

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Benzopiperazine compositions as BET bromodomain inhibitors

Tetrahydroquinoline compositions as BET bromodomain inhibitors

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Compositions for activating pyruvate kinase